Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Pera

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Respiration; International Review of Thoracic Diseases|January 3, 2022
Real-World Effects of Antibiotic Treatment on Acute COPD Exacerbations in Outpatients: A Cohort Study under the PharmLines InitiativeYuanyuan Wang, Victor Pera, H Marike Boezen, et al.
Pharmacoepidemiology and Drug Safety|September 4, 2025
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System (FAERS) to RxNorm and Anatomical Therapeutic Chemical (ATC) CodesRowan E Parry, Victor Pera, Katia M C Verhamme, et al.
Drug Safety|September 19, 2024
Disproportionality Analysis and Characterisation of Medication Errors in EudraVigilance: Exploring Findings on Sexes and Age GroupsVictor Pera, Jan A Kors, Erik M van Mulligen, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 18, 2025
Macrolide prescribing and preemptive electrocardiograms in asthma, COPD, ACO, and general population: a drug-utilization studyVictor Pera, Heleen Lepouttre, Cesar Barboza, et al.
Mayo Clinic Proceedings. Digital Health|July 2, 2025
Implementation and Updating of Clinical Prediction Models: A Systematic ReviewAlexander Saelmans, Tom Seinen, Victor Pera, et al.
Frontiers in Pharmacology|November 30, 2023
Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration's adverse event reporting system (FAERS)Victor Pera, Guy G Brusselle, Sebastian Riemann, et al.
Pharmacoepidemiology and Drug Safety|December 29, 2023
Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting SystemVictor Pera, Frauke van Vaerenbergh, Jan A Kors, et al.
Journal of the American Medical Informatics Association : JAMIA|April 27, 2022
Use of unstructured text in prognostic clinical prediction models: a systematic reviewTom M Seinen, Egill A Fridgeirsson, Solomon Ioannou, et al.
Journal of the American Medical Informatics Association : JAMIA|February 24, 2023
Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational studyAnna Ostropolets, Yasser Albogami, Mitchell Conover, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Respiration; International Review of Thoracic Diseases|January 3, 2022
Real-World Effects of Antibiotic Treatment on Acute COPD Exacerbations in Outpatients: A Cohort Study under the PharmLines InitiativeYuanyuan Wang, Victor Pera, H Marike Boezen, et al.
Pharmacoepidemiology and Drug Safety|September 4, 2025
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System (FAERS) to RxNorm and Anatomical Therapeutic Chemical (ATC) CodesRowan E Parry, Victor Pera, Katia M C Verhamme, et al.
Drug Safety|September 19, 2024
Disproportionality Analysis and Characterisation of Medication Errors in EudraVigilance: Exploring Findings on Sexes and Age GroupsVictor Pera, Jan A Kors, Erik M van Mulligen, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 18, 2025
Macrolide prescribing and preemptive electrocardiograms in asthma, COPD, ACO, and general population: a drug-utilization studyVictor Pera, Heleen Lepouttre, Cesar Barboza, et al.
Mayo Clinic Proceedings. Digital Health|July 2, 2025
Implementation and Updating of Clinical Prediction Models: A Systematic ReviewAlexander Saelmans, Tom Seinen, Victor Pera, et al.
Frontiers in Pharmacology|November 30, 2023
Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration's adverse event reporting system (FAERS)Victor Pera, Guy G Brusselle, Sebastian Riemann, et al.
Pharmacoepidemiology and Drug Safety|December 29, 2023
Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting SystemVictor Pera, Frauke van Vaerenbergh, Jan A Kors, et al.
Journal of the American Medical Informatics Association : JAMIA|April 27, 2022
Use of unstructured text in prognostic clinical prediction models: a systematic reviewTom M Seinen, Egill A Fridgeirsson, Solomon Ioannou, et al.
Journal of the American Medical Informatics Association : JAMIA|February 24, 2023
Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational studyAnna Ostropolets, Yasser Albogami, Mitchell Conover, et al.
Pageof 1